Nephrology News
AS Safe for Cystic Renal Masses in Selected Patients
In a single-center study, 24% of patients crossed over to treatment and 95% of patients were alive after 5 years of follow-up.
By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/